Nivolumab/pembrolizumabVarious toxicities: 13 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1863卷 / 1期

关键词：

D O I：

10.1007/s40278-021-98882-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：278 / 278

相关论文

共 50 条

[31] Nivolumab/pembrolizumabVarious toxicities: 16 case reports
Reactions Weekly, 2019, 1770 (1) : 313 - 313
[32] Nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2022, 1918 (1) : 392 - 392
[33] PembrolizumabVarious toxicities: 13 case reports
Reactions Weekly, 2023, 1977 (1) : 247 - 247
[34] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1685 (1) : 117 - 117
[35] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1864 (1) : 203 - 203
[36] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 8 case reports
Reactions Weekly, 2020, 1791 (1) : 153 - 153
[37] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 6 case reports
Reactions Weekly, 2021, 1849 (1) : 252 - 252
[38] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 2 case reports
Reactions Weekly, 2023, 1960 (1) : 248 - 248
[39] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 10 case reports
Reactions Weekly, 2021, 1840 (1) : 227 - 227
[40] Atezolizumab/nivolumab/pembrolizumabVarious toxicities: 20 case reports
Reactions Weekly, 2025, 2042 (1) : 63 - 63

← 1 2 3 4 5 →